Dark Pharma · DP-027
SHE APPROVED THE INVOICE FOR £47,000. THE SAME DRUG COST £39 THE YEAR BEFORE. THE CLINICAL AUTHORITY SAID THERE WAS NO APPEAL.
In July 2017, a procurement officer processed an invoice for hydrocortisone tablets priced at £47,000 per pack—up from just £39 the previous year. Despite the shocking increase, the authority had no appeal mechanism to contest the price.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.